Alvotech (ICE:ALVO)
Iceland · Delayed Price · Currency is ISK 1,130.00
-20.00 (-1.74%)
At close: Aug 1, 2025
Alvotech Employees
Alvotech had 1,012 employees as of December 31, 2024. The number of employees increased by 13 or 1.30% compared to the previous year.
Employees
1,012
Change (1Y)
13
Growth (1Y)
1.30%
Revenue / Employee
$76,669,686
Profits / Employee
$12,590,918
Market Cap
340.57B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,012 | 13 | 1.30% |
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Marel | 7,500 |
| Íslandsbanki | 764 |
| Arion banki | 822 |
| Sildarvinnslan Hf. | 723 |
| Brim hf. | 694 |
| Hagar | 2,699 |
| Kvika banki | 270 |
| Festi | 1,352 |
Alvotech News
- 23 days ago - Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer - GlobeNewsWire
- 23 days ago - Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer - GlobeNewsWire
- 24 days ago - Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in Switzerland - GlobeNewsWire
- 24 days ago - Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland - GlobeNewsWire
- 4 weeks ago - Notification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuers - GlobeNewsWire
- 4 weeks ago - Granting of Stock Options and Vesting of Restricted Share Units - GlobeNewsWire
- 4 weeks ago - Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol) - GlobeNewsWire
- 4 weeks ago - Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol) - GlobeNewsWire